Establishment Labs Holdings (ESTA) has drawn fresh attention after recent share price moves, with the stock up about 10% over the past month but down roughly 6% in the past 3 months.

At around $69.08 per share, the stock has recently pulled back, with a 7-day share price return of 7.32% and a 90-day share price return of 6.06%. However, the 1-year total shareholder return is 89.47%, which suggests that longer term momentum remains stronger than the latest move.

If you are comparing Establishment Labs Holdings with other healthcare related growth ideas, this could be a good moment to broaden your watchlist with 33 healthcare AI stocks

So with Establishment Labs Holdings still loss-making on revenue of $229.576 million, yet trading around $69.08 per share after a strong 1-year run, is there real value left here, or is the market already pricing in future growth?

Most Popular Narrative: 30% Undervalued

With Establishment Labs Holdings last closing at $69.08 and the most followed narrative pointing to a fair value near $69.31 using an 8.1% discount rate, the story hinges on how future growth and profitability play out.

The bearish analysts expect earnings to reach $30.9 million (and earnings per share of $0.97) by about April 2029, up from $51.1 million of losses today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $74.9 million.

Want to understand why an unprofitable company can still support a higher fair value? The narrative leans on rapid revenue expansion, improving margins, and a rich future earnings multiple. Curious which specific profitability milestones and growth rates have to line up for that price to hold? The full story connects those moving parts into one tight valuation case.

Result: Fair Value of $69.31 (UNDERVALUED)

However, there are still clear risks, including slower cosmetic procedure demand and tighter implant regulations, that could challenge revenue assumptions and put pressure on the current narrative.

Another Way To Look At Valuation

The community fair value narrative suggests Establishment Labs Holdings is about fairly priced around $69.31, yet the SWS DCF model points to a future cash flow value of $50.91, which screens as overvalued at the current $69.08 share price. Which framework better matches how you think cash flows should be priced?

Next Steps

With mixed signals on value, risk, and reward, this is the kind of setup where it pays to look under the hood yourself and move quickly. To see how the positives and concerns stack up side by side, take a closer look at the 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

Do not stop your research with just one stock. Broaden your options now so you do not miss opportunities that could better match your goals and risk comfort.

• Target potential mispricings by scanning for quality companies trading below their estimated worth with the 47 high quality undervalued stocks.
• Strengthen your income focus by reviewing companies that offer solid yields and balance income needs with resilience through the 14 dividend fortresses.
• Unearth lesser known opportunities that still pass strict fundamental checks by running the screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.